In vivo regulation of plasminogen function by plasma carboxypeptidase B

  • 0Department of Molecular Cardiology, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA.

|

|

Summary

This summary is machine-generated.

Plasma carboxypeptidase B (pCPB) suppresses plasminogen (Plg) functions. Mice lacking pCPB showed increased fibrinolysis and leukocyte migration, confirming pCPB

Area Of Science

  • Biochemistry
  • Physiology
  • Molecular Biology

Background

  • Plasminogen (Plg) functions in fibrinolysis and cell migration are crucial and depend on binding to carboxy-terminal lysyl residues.
  • Plasma carboxypeptidase B (pCPB) removes these lysyl residues, suggesting a potential suppressive role in Plg-dependent processes.

Purpose Of The Study

  • To investigate the in vivo role of plasma carboxypeptidase B (pCPB) as a suppressor of plasminogen (Plg) functions.
  • To evaluate the impact of pCPB deficiency on fibrinolysis and leukocyte migration in a mouse model.

Main Methods

  • Generation of pCPB-deficient mice (pCPB(-/-)) via homologous recombination.
  • Cross-mating of pCPB(-/-) mice with Plg-deficient mice (Plg(-/-)) to create Plg(+/-)/pCPB(+/-) and Plg(+/-)/pCPB(-/-) mouse models.
  • Assessment of fibrinolysis using a pulmonary clot lysis model and leukocyte migration in a thioglycollate-induced peritoneal inflammation model.

Main Results

  • Fibrinolysis was significantly enhanced in pCPB-deficient mice (both partial and total deficiency) compared to wild-type controls in a pulmonary clot lysis model.
  • Leukocyte migration at 72 hours was significantly increased in mice with partial or total absence of pCPB in a peritoneal inflammation model.
  • These findings were observed in a background of partial plasminogen deficiency (Plg(+/-)).

Conclusions

  • Plasma carboxypeptidase B (pCPB) plays a definitive role in modulating the essential functions of plasminogen (Plg) in vivo.
  • pCPB acts as a suppressor of Plg-dependent fibrinolysis and leukocyte migration.

Related Concept Videos